Thomas GronfeldtOne of the things that made me delete my Twitter account (long before moving to Mastodon, so not spurred by the Musk take-over) was the negativity that pervaded the platform. So on this new platform, I'm going to fly the optimism flag! As David Tennant said, we need to postively defiant and defiantly positive. So every Friday, I'll post a "good news of the week", starting today.
Whoops! One week in, and I'm already late. Oh well, here goes: This week's good news is that a new study has seen great results from using a patient's own immune cells, multiplied in a lab, to combat metastatic melanoma, one of the most aggressive forms of cancer. Any breakthrough in this area is great news! https://www.sciencedaily.com/releases/2022/12/221207183650.htm.
Patient's own immune cells effective as living medicine for melanoma
A patient's own immune cells, multiplied into an army of billions of immune cells in a lab, can be used as a living medicine against metastatic melanoma, an aggressive form of skin cancer, as the TIL trial has shown. The TIL trial is the world's first comparative phase 3 trial looking into the effect of T cell therapy in melanoma, and solid tumors in general.
JayThe+pi@tgs thanks alot for this information
This Friday's bit of #techoptimism, in the form of the #goodnews of the week: medical company Moderna has an mRNA cancer vaccine in testing that is showing a lot of promise. In a study on skin cancer, it reduced recurrence and death by a whopping 44 %, giving hope that in a very near future, we may have a vaccine for some kinds of the dreaded illness. https://www.freethink.com/health/mrna-cancer-vaccine?utm_source=tldrnewsletter
